Stangest Oncovet Ii 240 Gr Powder

L Glutamic acid: 150 mg, Silybum marianum (Milk thistle extract, silymarin): 100 mg, Punica granatum (Pomegranate): 125 mg, Camellia Sinensis (Green tea): 100 mg, Curcuma longa (Curcumin): 50 mg, Vitis vinifera (Grape seed): 20 mg, L Selenomethionine: 1 mg (Selenium: 0.02 mg), Excipients q.s .

Amino acid involved in numerous biochemical reactions, including the formation of nucleotides, amino acids and glycogen . L-glutamic acid is a substrate for the de novo synthesis of glutamine . It acts directly on gut-associated lymphoid tissue , stimulating the immune system and protecting the intestinal mucosa .

Its main component is silymarin, which acts as an antioxidant. It also increases endogenous antioxidant capacity by increasing glutathione concentration and superoxide dismutase activity. Silymarin has anti-metastatic, anti-angiogenic and anti-inflammatory activity, inhibits cell proliferation and induces apoptosis .

Rich in ellagic acid, which binds to and deactivates various carcinogenic substances and has anti-mutagenic properties. Inhibits angiogenesis and the cell cycle. It has anti-inflammatory and antioxidant effects.

OncoVet works as a nutritional support for all types of neoplastic diseases, in treatments with and without chemotherapy or addiotherapy and pre- or post-surgical support. Indicated in mammary tumours. All cancer patients (99%) suffer from nutritional deficiencies that are difficult to counteract, as the biochemical processes of organic regulation are greatly compromised. Supplementation with Biocomplex Antioxidant is recommended.

Administration: 1 tablet per 10 kg of body weight, twice a day.